BCAL Diagnostics Limited (ASX:BDX)
Australia
· Delayed Price · Currency is AUD 0.0870
+0.0030 (3.57%)
Apr 28, 2025, 4:10 PM AEST
BCAL Diagnostics Revenue
BCAL Diagnostics had revenue of 1.39M AUD in the half year ending December 31, 2024, with 37.47% growth. This brings the company's revenue in the last twelve months to 2.62M, down -29.28% year-over-year. In the fiscal year ending June 30, 2024, BCAL Diagnostics had annual revenue of 3.10M with 8.60% growth.
Revenue (ttm)
2.62M
Revenue Growth
-29.28%
P/S Ratio
11.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
30.74M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |